State Ledger
Company profile

INTENSITY THERAPEUTICS, INC. CIK 1567264

Ticker
INTS (Nasdaq)
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Shelton, CT 06484
Fiscal year end
2025 (FY)
Market Data
Close
$3.61
Change
+$0.00
Change %
0.00%
Volume
0

INTS · trading date Oct 8, 2026 · previous close $3.61 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$11.61M
Total assets
$14.10M
Total liabilities
$2.23M
Stockholders' equity
$11.88M
Cash & equivalents
$11.92M
Operating income
-$11.97M
Operating cash flow
-$9.23M
Capital expenditures
—

Fiscal year 2025, via 10-K filed 2026-03-27. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
15.8%
Equity / assets
84.2%
CapEx / revenue
—
Operating cash flow / net income
0.80×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$11.61M $14.10M $2.23M $11.88M
2024 — -$16.27M $4.78M $1.87M $2.92M
2023 — -$10.54M $17.30M $4.13M $13.16M
2022 — -$7.58M $1.76M $6.86M -$15.10M
Company Details
SIC code
2836
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-08-11
Financials filed via
Form 10-K
filed 2026-03-27

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Shelton, CT 06484
1 ENTERPRISE DRIVE, SUITE 430
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:22 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Connecticut — Public Companies